Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:e137
doi: 10.1161/01.CIR.0000099920.64559.E2
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, T. O.
Right arrow Articles by Di Mario, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, T. O.
Right arrow Articles by Di Mario, C.
Related Collections
Right arrow Other Ethics and Policy
Right arrow Restenosis
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Catheter-based coronary interventions: stents

(Circulation. 2003;108:e137.)
© 2003 American Heart Association, Inc.


Correspondence

The SIRIUS Trial Is Not a Sirius Trial

Tsung O. Cheng, MD

Department of Medicine, George Washington University, Washington, DC

To the Editor:

Acronyms should always be capitalized to avoid confusion with common words.1 In the recent Brief Rapid Communications article by Colombo et al2 about restenosis after implantation of drug-eluting stents, the authors mentioned the SIRIUS trial, which stands for SIRolImUS-coated stent in treatment of patients with de novo coronary artery lesions.1 But in the Discussion of the article, the authors did not capitalize the acronym SIRIUS; instead, they referred to it simply as the Sirius trial.

Perhaps it was simply a typographical error. However, the fact that it appeared in uncapitalized form four times after it initially appeared in capitalized form in the Introduction made me wonder. In astronomy, Sirius is a star in the constellation Canis Major, the brightest star in the sky. Perhaps the authors subconsciously were comparing the SIRIUS trial to the star Sirius. But such a deviation from the rules issued by the International Committee of Medical Journal Editors3 created a problem to the readers of your journal. How are the uninitiated readers going to know if such a word is an acronym or an ordinary word4? Witty acronyms such as ALIVE, BRILLIANT, BRITE, CURE, GUARANTEE, HOPE, IMPROVED, MIRACLE, and SAVED (for their definitions, please see Reference 1) may subtly play on the hopes or dreams of patients or investigators, thus constituting a form of coercion5 that should be discouraged in a peer-reviewed journal. These acronyms certainly should never be allowed to appear in uncapitalized forms in any manuscript.1

References

  1. Cheng TO, Julian D. Acronyms of cardiologic trials—2002. Int J Cardiol. 2003; 91: 261–351.[CrossRef][Medline] [Order article via Infotrieve]
  2. Colombo A, Orlic D, Stankovic G, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation. 2003; 107: 2178–2180.[Abstract/Free Full Text]
  3. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med. 1997; 336: 309–315.[Free Full Text]
  4. Cheng TO. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice. Cardiology. 1996; 87: 267.[Medline] [Order article via Infotrieve]
  5. Orlowski JP, Christensen JA. The potentially coercive nature of some clinical research trial acronyms. Chest. 2002; 121: 2023–2028.[Abstract/Free Full Text]

 

Response

Antonio Colombo, MD; Dejan Orlic, MD; Goran Stankovic, MD; Nicola Corvaja, MD; Vassilis Spanos, MD; Matteo Montorfano, MD; Francesco Liistro, MD; Mauro Carlino, MD; Flavio Airoldi, MD; Alaide Chieffo, MD; Carlo Di Mario, MD

Cardiac Catheterization Laboratory, Columbus Hospital, Milan, Italy

We appreciate the remarks of Dr Cheng regarding the need to capitalize acronyms. We also agree with the value of being precise in order not to confuse the reader. Concerning the SIRIUS trial, the remarks of Dr Cheng give us the opportunity to look at this study as a "bright star" in the world of interventional cardiology. Maybe this element is always present subconsciously in people who propose different trial names. Maybe it is also a freudian lapse in our minds, because we were so profoundly caught up by the results of this trial. We also think that when the manuscript of the SIRIUS trial is published, readers will agree that the SIRIUS trial is a Sirius trial.




This article has been cited by other articles:


Home page
CirculationHome page
J. T. Willerson
November 11, 2003
Circulation, November 11, 2003; 108(19): 2291 - 2291.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, T. O.
Right arrow Articles by Di Mario, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, T. O.
Right arrow Articles by Di Mario, C.
Related Collections
Right arrow Other Ethics and Policy
Right arrow Restenosis
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Catheter-based coronary interventions: stents